Fundamentals

Valuation

Metric	Q2	Q3	Δ in %
EV/EBITDA	99.93	-16.02	-24605.66
Graham Fair Price	-95.53	2.32	51.77
PEG	-100.00	< 0.005	0.00
Price/Book	58029.93	0.04	< 0.005
Price/Cash Flow	70.94	-10.02	-34.46
Prices/Earnings	70.94	-0.48	-1.64
Price/Sales	0.00	0.00	0.00
Price/FCF	70.94	-10.02	-34.46
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q2	Q3	Δ in %
Gross Profit Margin	0.00	0.00	0.00
Operating Margin	0.00	0.00	0.00
ROA	-199900.00	-0.01	< 0.005
ROE	< 0.005	-0.02	-199900.00
ROIC	< 0.005	-0.01	-190280.24
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q2	Q3	Δ in %
Debt QOQ	< 0.005	0.00	100.00
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.00	-1999.00	-100.00
EPS QOQ	0.00	-1.00	-100.00
FCF QOQ	0.00	-1999.00	-100.00
Revenue QOQ	0.00	0.00	0.00
Naive Interpretation	member

03 - Financial Growth · Bad

Fundamentals

Leverage & Liquidity

Metric	Q2	Q3	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.19	0.23	20.35
Quick Ratio	< 0.005	< 0.005	0.00
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q2	Q3	Δ in %
Book Value	3178.71	3.18	-99.90
Cash	1.68	< 0.005	-99.90
Capex	0.00	0.00	0.00
Free Cash Flow	< 0.005	-0.01	-100.00
Revenue	0.00	0.00	0.00
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q2	Q3	Δ in %
Current Ratio	0.35	0.35	0.00
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-24597.59	-13.47	99.95
Naive Interpretation	Member

06 - Financial Health · Bad

Rating